Navigation Links
Nephros Completes Bridge Financing and Announces Stockholder Rights Offering
Date:10/1/2010

RIVER EDGE, N.J., Oct. 1 /PRNewswire-FirstCall/ -- Nephros, Inc. (OTC Bulletin Board: NEPH), a medical device company developing and marketing filtration products for therapeutic applications, infection control, and water purification, today announced that the company has entered into a bridge financing agreement with Lambda Investors LLC and has filed a registration statement for a rights offering to its stockholders.  Wexford Capital LP is the managing member of Lambda Investors.

On October 1, 2010, the company issued a six-month senior secured note to Lambda Investors in the principal amount of $500,000.  The company expects that the proceeds from the note will allow it to fund its operations into February 2011.

As required under the terms of the note, the company has undertaken to conduct a rights offering to raise $3,500,000 from its existing stockholders.  All of the company's stockholders as of the record date for the rights offering, which date will be determined by the company at a later date, will be eligible to participate in the rights offering on a pro rata basis.  Pursuant to the rights offering, Nephros is offering up to 175 million units at a price of $0.02 per unit.  Stockholders will have the right to purchase 4.185496618 units for each share of Nephros stock owned.  Each unit consists of one share of common stock and a warrant to purchase 0.924532845 shares of common stock at an exercise price of $0.02 per share for a period of five years.  Lambda Investors' loan terms included its agreement to surrender for cancellation up to approximately 50% of its existing warrants, after giving effect to the full ratchet anti-dilutive adjustment contained in those warrants that will be triggered by the rights offering.  The number of cancelled Lambda warrants will be equal to the aggregate number of shares underlying the w
'/>"/>

SOURCE Nephros, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Nephros Reports 2010 Second Quarter Financial Results
2. Nephros Receives Formal Response from FDA for 510(k) Application for Hemodiafiltration System
3. Nephros and AmeriWater Announce Dual Stage Ultrafilters to be a Standard Component of MRO Series Water Treatment Systems
4. Nephros Reports 2010 First Quarter Financial Results
5. Nephros Signs Development Agreement with STERIS
6. Nephros Signs Canadian Distribution Agreement with Bellco Health Care Inc.
7. Nephros Reports 2009 Third Quarter Financial Results
8. Nephros Completes Pivotal U.S. Clinical Trial for its Hemodiafiltration Products
9. Tigris Pharmaceuticals, Inc. Completes $6.5 Million Private Placement
10. Johnson & Johnson Completes Acquisition of Micrus Endovascular
11. Endo Pharmaceuticals Successfully Completes Tender Offer for Shares of Penwest Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... , July 29, 2014  Encision Inc. (OTCQB:ECIA), a ... dangerous stray electrosurgical burns in minimally invasive surgery, today ... ended June 30, 2014. The Company posted ... net loss of $202 thousand, or $(0.02) per share. ... for a net loss of $311 thousand, or $(0.04) ...
(Date:7/29/2014)... , Next phase of ... has commenced , TPM®/Oxycodone Phase 2a trial ... 2014 , TPM®/Oxymorphone Phase 2 trial to ... Australian drug delivery company, Phosphagenics Limited (ASX: ... programs after its recent announcement of a $19.2 million capital raising. ...
(Date:7/29/2014)...   Health 2.0 announces Bernard Tyson , ... Eric Topol , Patrick Soon-Shiong , and Samsung,s ... 8th Annual Fall Conference this coming Sept. 21-24 in ... 2.0 is set to host the very first Wearable Tech ... Consumer Tech & Wearables: Powering Healthy Lifestyles. The ...
Breaking Medicine Technology:Encision Reports First Quarter Fiscal Year 2015 Results 2Encision Reports First Quarter Fiscal Year 2015 Results 3Encision Reports First Quarter Fiscal Year 2015 Results 4Phosphagenics Provides Update on Opioid Patch Program 2Phosphagenics Provides Update on Opioid Patch Program 3Phosphagenics Provides Update on Opioid Patch Program 4Phosphagenics Provides Update on Opioid Patch Program 5Phosphagenics Provides Update on Opioid Patch Program 6Kaiser Permanente CEO to Keynote Health 2.0 8th Annual Fall Conference 2Kaiser Permanente CEO to Keynote Health 2.0 8th Annual Fall Conference 3
... Hospira, Inc. (NYSE: HSP ... announced positive results from a Phase I U.S. clinical ... renal (kidney) dysfunction who have anemia. Hospira,s trial met ... and distribution in the body, for Hospira,s EPO and ...
... 6, 2011 Omthera Pharmaceuticals, Inc., a privately-held emerging ... and Chief Executive Officer, will present at the Rodman ... 2011 at 2:25pm ET at the Waldorf Astoria Hotel ... Pharmaceuticals, Inc. Founded in 2008, Omthera ...
Cached Medicine Technology:Hospira Announces Positive Results From Phase I U.S. Clinical Trial of Biosimilar Erythropoietin in Renal Patients 2Hospira Announces Positive Results From Phase I U.S. Clinical Trial of Biosimilar Erythropoietin in Renal Patients 3
(Date:7/29/2014)... (PRWEB) July 29, 2014 According to an ... uterine fibroid was recently removed from a 52 year old ... woman, identified only as Latha, reportedly had no idea that ... had been experiencing fatigue and breathlessness for years, but did ... Kumaran Hospital in Chennai only discovered the massive uterine fibroid ...
(Date:7/29/2014)... Francisco, California (PRWEB) July 29, 2014 ... reach USD 9,542.3 million by 2020, growing at an ... to a new study by Grand View Research, Inc. ... of these devices by the geriatric population, along with ... some of the major drivers of this market. In ...
(Date:7/29/2014)... iFitDress.com, one of the most famous dress ... 2014 high low wedding dresses . Aside from that, ... at discounted prices, up to 68% off. All the company’s ... before August 05. , The company’s sales representative is ... dresses. In the new collection, there are numerous great gowns ...
(Date:7/29/2014)... 2014 On Friday, the United States ... week of October 12-18, 2014, as "National Case Management ... improving healthcare outcomes for patients. The resolution was introduced ... (R-AR), with support by the Case Management Society of ... case management professionals for their contributions to healthcare. , ...
(Date:7/29/2014)... California (PRWEB) July 29, 2014 ... of the peer-reviewed journal Lipids in Health and ... value—of Nordic Naturals triglyceride-form best-selling Ultimate Omega®/ProOmega®. Consistently ... according to SPINS scan data, the product was ... to other omega-3 products in the marketplace. The ...
Breaking Medicine News(10 mins):Health News:World’s Largest Uterine Fibroid Removed from Patient 2Health News:World’s Largest Uterine Fibroid Removed from Patient 3Health News:Audiology Devices Market Analysis by Product (Cochlear Implants, Bone Anchored Hearing Aids, Hearing Aids, Audiometers) Expected to Reach USD 9,542.3 Million by 2020 2Health News:Audiology Devices Market Analysis by Product (Cochlear Implants, Bone Anchored Hearing Aids, Hearing Aids, Audiometers) Expected to Reach USD 9,542.3 Million by 2020 3Health News:Audiology Devices Market Analysis by Product (Cochlear Implants, Bone Anchored Hearing Aids, Hearing Aids, Audiometers) Expected to Reach USD 9,542.3 Million by 2020 4Health News:Audiology Devices Market Analysis by Product (Cochlear Implants, Bone Anchored Hearing Aids, Hearing Aids, Audiometers) Expected to Reach USD 9,542.3 Million by 2020 5Health News:Audiology Devices Market Analysis by Product (Cochlear Implants, Bone Anchored Hearing Aids, Hearing Aids, Audiometers) Expected to Reach USD 9,542.3 Million by 2020 6Health News:2014 High Low Wedding Dresses Provided By iFitDress.com 2Health News:CMSA Supports National Case Management Week Resolution Introduced in US Senate 2Health News:Study Shows Nordic Naturals® Triglyceride-Form Ultimate Omega®/ProOmega® More Effective Than Krill Oil, Salmon Oil, and Ethyl Ester Fish Oil 2Health News:Study Shows Nordic Naturals® Triglyceride-Form Ultimate Omega®/ProOmega® More Effective Than Krill Oil, Salmon Oil, and Ethyl Ester Fish Oil 3
... release is available in French . , ... on possible links between cell phone use and brain ... collaborated on the Interphone International Study Group. Jack Siemiatycki, ... epidemiologist at the University of Montreal Hospital Research Center, ...
... HACKENSACK, N.J. (May 17, 2010) John Theurer Cancer Center ... is one of two cancer centers in the tri-state ... DVS (Dose Verification System). John Theurer Cancer Center radiation ... the precise amount of radiation being delivered to tumors ...
... could pave way for tests that predict the illness, researchers ... of serious lung disease in middle age may have genetic ... history of such illnesses in their background, a new study ... might enable doctors to screen for genetic predispositions to serious ...
... ... in the May 17 – 21 event , ... (PRWEB) May 17, 2010 -- Pedego® Electric Bicycles has ... throughout Northern California, has added the Pedego Comfort Cruiser line of electric bikes to ...
... ... keep Affiliates informed on how to achieve the highest conversion performance. , ... Encino, CA (PRWEB) May 14, ... technology concerning the affiliate marketing industry. Founded in 2006, T3Leads has since provided unparalleled ...
... ... Patients Reverse Sun Damage and Restore the Health of Their Skin without Painful Surgery ... Los Angeles ... damage, resulting in wrinkles, sagging, age spots, discoloration and other unsightly symptoms. While a ...
Cached Medicine News:Health News:World's biggest study on cell phones and brain cancer inconclusive 2Health News:John Theurer Cancer Center offers breakthrough radiation measurement technology 2Health News:Lung Disease Can Be Genetic Even Without Family History 2Health News:T3Leads Provides Latest Industry News: Imperative Information to Help Publishers Maximize Profits 2Health News:T3Leads Provides Latest Industry News: Imperative Information to Help Publishers Maximize Profits 3Health News:Epione Reveals a ‘Bright' New Solution for Dull, Sun Damaged Skin 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: